HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Huda Beauty To Settle Class Action Over Eyeshadows ‘Not Intended For The Eye Area'

Executive Summary

US consumers who purchased Neon Obsession pressed pigment palettes may be entitled to refunds under a settlement preliminarily approved in California’s Central District. Plaintiffs say Huda promoted Neon Obsession as eyeshadow despite use of color additives not approved by the FDA for eye-area use, an issue that cannot be cured by a “buried” disclaimer on product packaging.

You may also be interested in...



First Huda, Now Morphe Faces Proposed Nationwide Class Action Over Eyeshadow Colors

A class action in California federal court targets Morphe Cosmetics for the sale and marketing of eyeshadows containing unapproved colors for eye-area use that three consumers say inflicted physical injury. They seek to represent consumers nationwide, citing breach of warranties, negligence, false advertising, and other claims.

Huda Beauty Flouts US Law With Neon Obsession, Ahem, ‘Multiuse Pigments’ – Class Action

Huda Beauty clearly intends for its Neon Obsession color palettes to be used as eyeshadow, despite a “hidden disclaimer” contraindicating the products for eye-area use, according to the plaintiff in a proposed class action filed in California’s Central District.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel